A transthoracic and transesophageal echocardiographic study. Am Heart J. 1997;134(4):745-751. 157. Page RL, Wilkinson WE, Clair WK, McCarthy EA, Pritchett EL. Asymptomatic arrhythmias in patients with symptom- atic paroxysmal atrial brillation and paroxysmal supraven- tricular tachycardia. Circulation. 1994;89(1):224-227. 158. Stoddard MF, Dawkins PR, Prince CR, Ammash NM. Left atrial appendage thrombus is not uncommon in patients with acute atrial brillation and a recent embolic event: a transesophageal echocardiographic study. J Am Coll Cardiol. 1995;25(2):452-459. 159. Kleemann T, Becker T, Strauss M, Schneider S, Seidl K. Pre- valence of left atrial thrombus and dense spontaneous echo contrast in patients with short-term atrial brillation ,48 hours undergoing cardioversion: value of transesophageal echocar- diography to guide cardioversion. J Am Soc Echocardiogr. 2009;22(12):1403-1408. 160. Flaker GC, Belew K, Beckman K, et al; AFFIRM Investi- gators. Asymptomatic atrial brillation: demographic fea- tures and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J. 2005;149(4):657-663. 161. Weigner MJ, Caul eld TA, Danias PG, Silverman DI, Manning WJ. Risk for clinical thromboembolism associ- ated with conversion to sinus rhythm in patients with atrial brillation lasting less than 48 hours. Ann Intern Med. 1997;126(8):615-620. 162. Arnold AZ, Mick MJ, Mazurek RP, Loop FD, Trohman RG. Role of prophylactic anticoagulation for direct current car- dioversion in patients with atrial brillation or atrial utter. J Am Coll Cardiol. 1992;19(4):851-855. 163. Chalasani P, Cambre S, Silverman ME. Direct-current car- dioversion for the conversion of atrial utter. Am J Cardiol. 1996;77(8):658-660. 164. Hart RG, Benavente O, McBride R, Pearce LA. Anti- thrombotic therapy to prevent stroke in patients with atrial brillation: a meta-analysis. Ann Intern Med. 1999;131(7): 492-501. 165. Fang MC, Chang Y, Hylek EM, et al. Advanced age, anti- coagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial brillation. 